3 Lung Cancer Stocks That Could Soar in September

3 Lung Cancer Stocks That Could Soar in September

Source: 
Motley Fool
snippet: 

Get ready for some market-moving presentations at the World Conference on Lung Cancer this September. Eli Lilly (NYSE: LLY), Amgen (NASDAQ: AMGN), and AstraZeneca (NYSE: AZN) are scheduled to present hotly anticipated results that could expand their presence in this important niche.